Julia E Vela Ramirez
Overview
Explore the profile of Julia E Vela Ramirez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vela Ramirez J, Boggiatto P, Wannemuehler M, Narasimhan B
ACS Biomater Sci Eng
. 2021 Jan;
3(2):160-168.
PMID: 33450792
An in-depth understanding of the interactions of vaccine delivery vehicles with antigen presenting cells is important for tailoring optimal adjuvant properties. Polymeric nanoparticles have been widely studied as adjuvants and...
2.
Wechsler M, Vela Ramirez J, Peppas N
Ind Eng Chem Res
. 2020 Sep;
58(33):15079-15087.
PMID: 32982041
Alzheimer's disease is an irreversible neurodegenerative disorder affecting approximately 6 million Americans, 90% of which are over the age of 65. The hallmarks of the disease are represented by amyloid...
3.
Liechty W, Scheuerle R, Vela Ramirez J, Peppas N
Int J Pharm
. 2019 Mar;
562:249-257.
PMID: 30858114
The progress of short interfering RNA (siRNA) technologies has unlocked the development of novel alternatives for the treatment of a myriad of diseases, including viral infections, autoimmune disorders, or cancer....
4.
Oldenkamp H, Vela Ramirez J, Peppas N
Regen Biomater
. 2019 Feb;
6(1):1-12.
PMID: 30740237
No abstract available.
5.
Liechty W, Scheuerle R, Vela Ramirez J, Peppas N
Bioeng Transl Med
. 2019 Jan;
4(1):17-29.
PMID: 30680315
The design of intracellular drug delivery vehicles demands an in-depth understanding of their internalization and function upon entering the cell to tailor the physicochemical characteristics of these platforms and achieve...
6.
Caldorera-Moore M, Vela Ramirez J, Peppas N
J Drug Target
. 2018 Nov;
27(5-6):582-589.
PMID: 30457357
Whereas significant advancements have been made in our fundamental understanding of cancer, they have not yet translated into effective clinical cancer treatments. One of the areas that has the potential...
7.
Brenza T, Schlichtmann B, Bhargavan B, Vela Ramirez J, Nelson R, Panthani M, et al.
J Biomed Mater Res A
. 2018 Oct;
106(11):2881-2890.
PMID: 30369055
An urgent need to deliver therapeutics across the blood-brain barrier (BBB) underlies a paucity of effective therapies currently available for treatment of degenerative, infectious, traumatic, chemical, and metabolic disorders of...
8.
Orive G, Santos-Vizcaino E, Pedraz J, Hernandez R, Vela Ramirez J, Dolatshahi-Pirouz A, et al.
Prog Retin Eye Res
. 2018 Oct;
68:67-82.
PMID: 30342088
Millions of people worldwide suffer from debilitating, progressive, and often permanent loss of vision without any viable treatment options. The complex physiological barriers of the eye contribute to the difficulty...
9.
Vela Ramirez J, Sharpe L, Peppas N
Adv Drug Deliv Rev
. 2018 Sep;
139:158.
PMID: 30189272
No abstract available.
10.
Sharpe L, Vela Ramirez J, Haddadin O, Ross K, Narasimhan B, Peppas N
Biomacromolecules
. 2018 Aug;
19(9):3904.
PMID: 30141322
No abstract available.